Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1871)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (771)
Apply filters
Showing 676 to 700 of 1871
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Perioperative care in adults
NG180
19 August 2020
19 August 2020
Rehabilitation for adults with complex psychosis
NG181
19 August 2020
19 August 2020
Surgical site infections: prevention and treatment
NG125
11 April 2019
19 August 2020
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma
TA641
12 August 2020
12 August 2020
Gilteritinib for treating relapsed or refractory acute myeloid leukaemia
TA642
12 August 2020
12 August 2020
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer
TA643
12 August 2020
12 August 2020
Entrectinib for treating NTRK fusion-positive solid tumours
TA644
12 August 2020
12 August 2020
Deep brain stimulation for refractory epilepsy in adults
IPG678
12 August 2020
12 August 2020
Implanted vagus nerve stimulation for treatment-resistant depression
IPG679
12 August 2020
12 August 2020
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant
TA640
5 August 2020
5 August 2020
Transcranial magnetic stimulation for obsessive-compulsive disorder
IPG676
5 August 2020
5 August 2020
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease
IPG677
5 August 2020
5 August 2020
Artificial iris insertion for acquired aniridia
IPG674
22 July 2020
22 July 2020
Artificial iris insertion for congenital aniridia
IPG675
22 July 2020
22 July 2020
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer
TA638
1 July 2020
1 July 2020
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer
TA639
1 July 2020
1 July 2020
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)
TA634
30 June 2020
30 June 2020
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)
TA635
30 June 2020
30 June 2020
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)
TA636
30 June 2020
30 June 2020
Ranibizumab for treating diabetic retinopathy (terminated appraisal)
TA637
30 June 2020
30 June 2020
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
TA626
24 June 2020
24 June 2020
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention
IPG673
24 June 2020
24 June 2020
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia
MTG49
24 June 2020
24 June 2020
Ustekinumab for treating moderately to severely active ulcerative colitis
TA633
17 June 2020
17 June 2020
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)
DG39
17 June 2020
17 June 2020
Previous page
1
…
26
27
Current page
28
29
30
…
75
Page
28
of
75
Next page
Results per page
10
25
50
All
Back to top